Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine and Cognitive Remediation in Schizophrenia
NCT00628394Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Sep 2003
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atomoxetine in schizophrenia, sponsored by UT Southwestern Medical Center. Started Sep 2003; status: completed.
02
Drugs
atomoxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00628394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628394.